China Detains Ex-AstraZeneca Executive in Sign of Widening Probe

Oct. 25, 2024, 8:49 AM UTC

Chinese authorities are probing a former senior executive of AstraZeneca Plc in the country, local media outlets reported on Friday, in a sign Beijing is widening its scrutiny of the British pharmaceutical giant’s operations in mainland China.

Authorities recently detained Eva Yin, who is currently Chief Commercial Officer for the greater China region at Chinese drugmaker Beigene Ltd., Jiemian and 21st Century Business Herald reported. Before joining Beigene in January 2022, Yin had worked for AstraZeneca for more than 15 years, and had been general manager of the multinational company’s China oncology business.

The probe could be related ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.